Name

CytaBOM

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for CytaBOM

Name

Alternate Names

Chlorethazine Hydrochloride
Chlormethine Hydrochloride
Dichloromethyl-diethylamine-HCl
Mechlorethamine Hydrochloride
Meclorethamine
Mustargen
Mustargen-HCl
Mustine
Nitrogen Mustard
WR-147650
Valchlor

Abbreviations

HN2
NH2
NH2-HCl

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

000762
762

Primary Site

CLL
Hodgkin lymphoma
lung cancer
Non-Hodgkin lymphoma

Histology

None

Remarks

FDA approved uses on bronchogenic carcinoma, chronic lymphocytic leukemia, Hodgkin's lymphoma, Non-Hodgkin lymphoma, lymphosarcoma, and malignant effusion.

Coding

This drug should be coded

Name

Alternate Names

AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453

Abbreviations

ara-C
CA
HDA
HDARA-C

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

063878
63878

Primary Site

ALL
AML
CML
head and neck
Hodgkin's disease
leukemia
Meningeal leukemia
NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded

Name

Alternate Names

Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo

Abbreviations

BLE
BLEO
BLM

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

125066

Primary Site

Squamous cell cancers

Histology

None

Remarks

FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.

Coding

This drug should be coded

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded
Glossary